[1]Hoveyda,HamidR.;Fraser,GraemeL.;Dutheuil,Guillaume;ElBousmaqui,Mohamed;Korac,Julien;Lenoir,François;Lapin,Alexey;Noël,Sophie[ACSMedicinalChemistryLetters,2015,vol.6,#7,p.736-740]
[1]ACSMedicinalChemistryLetters,2015,vol.6,p.736-740
[1]Hoveyda,HamidR.;Fraser,GraemeL.;Dutheuil,Guillaume;ElBousmaqui,Mohamed;Korac,Julien;Lenoir,François;Lapin,Alexey;Noël,Sophie[ACSMedicinalChemistryLetters,2015,vol.6,#7,p.736-740]
[1]Hoveyda,HamidR.;Fraser,GraemeL.;Dutheuil,Guillaume;ElBousmaqui,Mohamed;Korac,Julien;Lenoir,François;Lapin,Alexey;Noël,Sophie[ACSMedicinalChemistryLetters,2015,vol.6,#7,p.736-740]
[1]CurrentPatentAssignee:ASTELLASPHARMAINC.-US2021/94955,2021,A1Locationinpatent:Paragraph0087-0091
Title: Fraser GL, et al. The NK3 Receptor Antagonist ESN364 Interrupts Pulsatile LH Secretion and Moderates Levels of Ovarian Hormones Throughout the Menstrual Cycle. Endocrinology. 2015 Nov;156(11):4214-25.